1.48 (-2.18%)
As of May 31, 2023
Source:
Tcr2 Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for cancer patients suffering from solid tumors by powering the T cell receptor with our proprietary, first-in-class TCR Fusion Construct T cells.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | 617-949-5200 |
| Industry | manufacturing |
| CEO | Garry E. Menzel |
| Website | www.tcr2.com |